NZSA Disclaimer FNZ should be a New Zealand success story. FNZ is a New Zealand-developed business that has gone on to challenge global practices. As FNZ proclaims, its employees have been the key to its success, with the company lauding the involvement of its “extraordinary FNZ’ers” within its ownership structure. It is that relationship with…
Read more
Annual Meeting Report, April 22nd 2025 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 2024 Change Revenue $172.4m $205.3m $238.7m $272.2m $319.9m 10% Fair Value Movement $222.1m $540.9m $268.8m $441.6m $372.6m -16% NPAT $230.8m $543.6m $225.4m $436.3m $339.8m -22% EPS1 $1.01 $2.36 $1.16 $1.86 $1.435 -23% PE Ratio 12 5…
Read more
NZSA Disclaimer Branch Event Report, April 15th 2025 On April 15th, our guest speaker was Marcus Driller of Fisher and Paykel Healthcare. Marcus joined the company in 2009 from Russell McVeagh, where he specialised in corporate and commercial law, and since that time has held several roles in legal, investor relations, and communications and most recently…
Read more
NZSA Disclaimer New Zealand’s Energy Giants Outline Ambitious Renewable Transition Strategy In a groundbreaking panel discussion hosted by the New Zealand Shareholders’ Association Top executives from the country’s major electricity generators revealed a comprehensive vision for New Zealand’s energy future, highlighting both the opportunities and challenges of decarbonisation. The panel, featuring CEOs from Meridian, Contact,…
Read more
New Zealand’s Electricity Leaders Face the Future Panellists from Meridian, Contact, Mercury, and Genesis explore the promise and pitfalls of renewable generation and the decarbonisation journey In a unique panel discussion hosted by the New Zealand Shareholders’ Association (NZSA), four of the country’s top energy executives gathered to confront a common challenge: how to deliver…
Read more
NZSA Company Visit to Fisher and Paykel Healthcare 18 March 2025 After our visit an attendee remarked to me that CEO Lewis Gradon was ‘on fire’ during his presentation to our members. He was personable, enthusiastic, knowledgeable and he stated that he enjoyed talking to NZSA members and felt he was ‘among friends’. In turn…
Read more
NZSA Disclaimer Over the last week or so, investors have been surprised by two separate actions in the local market, both having the potential outcome of removing all members of the Boards for NZ Media and Entertainment (NZME) and Bremworth (BRW). Both actions claim the support of a broader shareholder base, 32% in the case…
Read more
Annual Meeting Report, February 26th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 2024 Change Revenue $100.6m $105.7m $126.3m $169.9m $213.2m 26% Operating Expenses $93m $118.2m $146.7m $189.7m 29% EBITDA $12.1m $12.7m $8.1m $23.2m $23.6m 2% NPAT -$31.7m $3.2m -$3.3m $10.0m $9.5m -5% EPS1 -$0.321 $0.032 -$0.033 $0.098 $0.092…
Read more
NZSA Disclaimer A few weeks ago, we wrote about the proposed takeover of Millennium Copthorne (MCK) by its major shareholder, CDL Investments at $2.25/share. In that commentary, NZ Shareholders’ Association challenged the independent directors to demonstrate their independence by rejecting the offer and (in so doing) the ‘patronage’ offered by their majority shareholder. It was clearly…
Read more
NZSA Disclaimer The end of the golden summer came this time last week for Heartland Group (NZX: HGH) – and less than five months after the elevation of Andrew Dixson to the Chief Executive role, and only a few days before the announcement of Heartland’s 1H FY25 results. Dixson is doing what any newly-minted CEO…
Read more
